The conversation highlights the disconnect between traditional neurology and functional medicine, particularly regarding treatment options for cognitive decline. Patients often receive minimal support from neurologists, with many being told there’s nothing they can do. New antibody therapies may slow progression but fail to improve cognition meaningfully, emphasizing the need for an integrated approach to treatment.
